Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tohoku Alfresa is a prominent Japanese pharmaceutical wholesaler and a key subsidiary of Alfresa Holdings Corporation. Headquartered in Fukushima, the company manages the distribution of ethical pharmaceuticals, medical devices, and diagnostic reagents across the six prefectures of the Tohoku region. It serves as a vital link in the healthcare infrastructure, providing logistics solutions and drug information to medical institutions and pharmacies. The company was established in 2003 through the consolidation of several regional distributors to optimize supply chain operations in northern Japan. Beyond simple logistics, Tohoku Alfresa offers specialized support for hospital management and community-based integrated care systems. The company maintains a robust cold chain infrastructure to ensure the safe delivery of temperature-sensitive biologics and vaccines.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 東北アルフレッサ.